Classical CD14++CD16− monocytes were significantly more abundant in MS patients than in healthy control subjects whereas non-classical CD14+CD16++ monocytes were less frequent in MS patients (Figure 2). This evidence concerns the gene CD14 and myeloid sarcoma.